Patents Assigned to Euro-Celtique, S.A.
  • Patent number: 7468194
    Abstract: Disclosed in certain embodiments is a method of treating infections of an interior part of the human or animal body, comprising administering to said interior body part, a pharmaceutical preparation comprising a particulate carrier and an effective amount of an agent selected from the group consisting of an antiseptic agent, a wound-healing promoting agent and a combination thereof, to treat an infection at said interior body part.
    Type: Grant
    Filed: May 25, 2000
    Date of Patent: December 23, 2008
    Assignee: Euro-Celtique, S.A.
    Inventors: Wolfgang Fleischer, Karen Reimer
  • Publication number: 20080233178
    Abstract: The present invention provides abuse-resistant transdermal delivery devices containing an opioid agonist intended for analgesic purposes in pain patients.
    Type: Application
    Filed: February 15, 2005
    Publication date: September 25, 2008
    Applicant: EURO-CELTIQUE S.A.
    Inventors: Bruce Reidenberg, Ihor Shevchuk, Lino Tavares, Richard Maskiewicz, Kevin Long, Mohammed Shameem
  • Publication number: 20080214827
    Abstract: Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof.
    Type: Application
    Filed: February 2, 2005
    Publication date: September 4, 2008
    Applicant: EURO-CELTIQUE S.A.
    Inventors: R. Richard Goehring, John Whitehead, Bin Shao
  • Publication number: 20080200493
    Abstract: It is possible to effectively treat moderate to severe visceral pain by administering analgesic medications comprising the opioid oxycodone or pharmaceutically acceptable salts thereof. Visceral pain and especially acute (i.e. non-chronic) visceral pain can be effectively treated by administering oxycodone at a dosage which is lower than the corresponding dosage of other opioids like morphine.
    Type: Application
    Filed: January 17, 2006
    Publication date: August 21, 2008
    Applicant: EURO-CELTIQUE S.A.
    Inventors: Asbjorn Mohr Drewes, Lars Arendt Nielsen
  • Publication number: 20080194627
    Abstract: This invention relates aryl substituted pyridines of Formula I: or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein Ar and R1—R4 are set in the specification. The invention is also directed to the use of compounds of Formula I for the treatment of neuronal damage following global and focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and for the treatment, prevention or amelioration of both acute or chronic pain, as antitinnitus agents, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy.
    Type: Application
    Filed: September 11, 2006
    Publication date: August 14, 2008
    Applicant: Euro-Celtique S.A.
    Inventors: Bin Shao, R. Goehring, Samuel Victory
  • Patent number: 7393872
    Abstract: Methods of treating or preventing chronic pain or convulsion are disclosed by administering to an animal a sodium channel blocker and at least one of gabapentin and pregabalin. Also disclosed are pharmaceutical compositions and kits for the treatment or prevention of chronic pain or convulsion.
    Type: Grant
    Filed: August 21, 2003
    Date of Patent: July 1, 2008
    Assignee: Euro-Celtique S.A.
    Inventor: Nancy C Lan
  • Publication number: 20080146804
    Abstract: Disclosed are methods for making aldehydes and ketones comprising allowing the corresponding primary or secondary alcohol to react in the presence of trichoroisocyanuric acid, a compound of formula R1SR2 and a base. In one embodiment, the alcohol is a compound of formula (I): wherein R3 is a protecting group. Also disclosed are methods for making 3-O-protected morphine dienol carboxylates comprising allowing a compound of formula (I) to oxidize in the presence of a chlorine-containing compound and a compound of formula R1SR2; and allowing the product of the oxidation step to react with an acylating agent.
    Type: Application
    Filed: February 4, 2005
    Publication date: June 19, 2008
    Applicant: EURO-CELTIQUE S.A.
    Inventor: Andreas Stumpf
  • Publication number: 20080132702
    Abstract: The present invention is directed to a process for reducing the level of ?, ?-unsaturated ketone in an opioid analgesic composition by hydrogenation with diimide or a diimide progenitor.
    Type: Application
    Filed: February 27, 2006
    Publication date: June 5, 2008
    Applicant: Euro-Celtique S.A.
    Inventor: Robert J. Kupper
  • Patent number: 7364749
    Abstract: Use of an anti-infective and/or anti-inflammatory agent for the preparation of a pharmaceutical composition for the treatment of diseases of external or internal parts of the human or animal body which are susceptible to the administration of such agents.
    Type: Grant
    Filed: May 25, 2000
    Date of Patent: April 29, 2008
    Assignee: Euro-Celtique, S.A.
    Inventors: Wolfgang Fleischer, Karen Reimer
  • Patent number: 7342017
    Abstract: A compound of formula: (wherein X, R1, R3, R4, and R5 are disclosed herein) or a pharmaceutically acceptable salt thereof (a “Thiadiazolylpiperazine Compound”), pharmaceutical compositions comprising a Thiadiazolylpiperazine Compound, and methods for treating or preventing, e.g., pain, depression and anxiety, in a patient comprising administering to a patient in need thereof an effective amount of a Thiadiazolylpiperazine Compound are disclosed.
    Type: Grant
    Filed: October 7, 2005
    Date of Patent: March 11, 2008
    Assignee: Euro-Celtique S.A.
    Inventors: Donald J. Kyle, Qun Sun
  • Publication number: 20080026042
    Abstract: A method of treating postoperative pain in a patient undergoing a surgery id described. The method is based on preoperative administration of a buprenorphine-containing transdermal dosage form. The dosage form can be administered to the patient, for example, 1-4 days prior to surgery. Alternative embodiments of the invention include subsequent transdermal dosage forms to treat the postoperative pain.
    Type: Application
    Filed: July 26, 2004
    Publication date: January 31, 2008
    Applicant: Euro-Celtique S.A.
    Inventors: Bruce E. Reidenberg, Daniel A. Spyker
  • Publication number: 20070298103
    Abstract: A neutral poly(ethyl acrylate, methyl methacrylate) copolymer is employed as a carrier in the manufacture of pharmaceutical formulations containing an active ingredient. The formulations are preferably made by melt extrusion, and can have rubbery characteristics and can exhibit tamper resistance.
    Type: Application
    Filed: February 11, 2005
    Publication date: December 27, 2007
    Applicant: EURO-CELTIQUE S.A.
    Inventor: Geoffrey Gerard Hayes
  • Patent number: 7300667
    Abstract: Disclosed are compositions comprising antiseptic and wound healing agents for the treatment of diseases of the lower respiratory tract and methods.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: November 27, 2007
    Assignee: Euro-Celtique, S.A.
    Inventors: Wolfgang Fleischer, Karen Reimer
  • Patent number: 7297344
    Abstract: Use of anti-inflammatory agents such as povidone iodine for the preparation of a pharmaceutical composition for the treatment of diseases of the upper respiratory tract and/or the ear which are susceptible to the administration of such agents.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: November 20, 2007
    Assignee: Euro-Celtique, S.A.
    Inventors: Wolfgang Fleischer, Karen Reimer
  • Publication number: 20070259045
    Abstract: Disclosed in certain embodiments is a controlled release dosage form comprising a matrix comprising a pharmaceutically acceptable salt of an opioid analgesic in a controlled release material; wherein less than 25% of the opioid salt is released after 1 hour of in-vitro dissolution of the dosage form in 900 ml of Simulated Gastric Fluid with 20% ethanol using a USP Apparatus I (basket) apparatus at 100 rpm at 37 degrees C.°.
    Type: Application
    Filed: January 27, 2006
    Publication date: November 8, 2007
    Applicant: EURO-CELTIQUE S.A.
    Inventors: Richard Mannion, William Mckenna, Edward O'Donnell, Helen Danagher, Geoffrey Hayes, Hassan Mohammad, Derek Prater, Harjit Tamber, Walden Malcolm, Steve Whitelock, Wolfgang Fleischer, Udo Hahn, Christof Spitzley, Christian Leuner
  • Patent number: 7279493
    Abstract: A compound of formula: wherein A, Ar, R3, R6, and m are disclosed herein, or a pharmaceutically acceptable salt thereof (a “Cyanoiminopiperazine Compound”), compositions comprising an effective amount of a Cyanoiminopiperazine Compound, and methods for treating or preventing pain, urinary incontinence, an ulcer, inflammatory-bowel disease, irritable-bowel syndrome, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia or depression in an animal comprising administering to an animal in need thereof an effective amount of a Cyanoiminopiperazine Compound are disclosed.
    Type: Grant
    Filed: June 27, 2003
    Date of Patent: October 9, 2007
    Assignee: Euro-Celtique S.A.
    Inventors: Donald J. Kyle, Qun Sun, Laykea Tafesse, Chongwu Zhang, Xiaoming Zhou
  • Patent number: 7262194
    Abstract: A compound of formula: wherein X is S or O and A, R1-R4, n, and m are disclosed herein, or a pharmaceutically acceptable salt thereof (a “Pyridazinylpiperazine Compound”), compositions comprising a Pyridazinylpiperazine Compound, and methods for treating or preventing pain, UI, an ulcer, IBD and IBS in an animal comprising administering to an animal in need thereof an effective amount of a Pyridazinylpiperazine Compound are disclosed herein.
    Type: Grant
    Filed: July 24, 2003
    Date of Patent: August 28, 2007
    Assignee: Euro-Celtique S.A.
    Inventors: Donald J. Kyle, Qun Sun
  • Patent number: 7256193
    Abstract: A Compound of formula (wherein X is O or S and R1-R5 are disclosed herein) or a pharmaceutically acceptable salt thereof (each being a “Piperazine Compound”), pharmaceutical compositions comprising a Piperazine Compound and methods for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia, or depression in an animal comprising administering to an animal in need thereof an effective amount of a Piperazine Compound are disclosed.
    Type: Grant
    Filed: March 2, 2006
    Date of Patent: August 14, 2007
    Assignee: Euro-Celtique S.A.
    Inventors: Donald J. Kyle, Sun Qun
  • Patent number: D561821
    Type: Grant
    Filed: June 15, 2005
    Date of Patent: February 12, 2008
    Assignee: Euro-Celtique S.A.
    Inventors: Stefaan Schatteman, Kris Schellens
  • Patent number: D573175
    Type: Grant
    Filed: June 22, 2007
    Date of Patent: July 15, 2008
    Assignee: Euro-Celtique S.A.
    Inventors: Stefaan Schatteman, Kris Schellens